400 related articles for article (PubMed ID: 19328972)
1. A prudent algorithm for hyperlipoproteinemia in renal transplant recipients.
Nart A; Uslu A; Bozkaya G; Aykas A; Dogan M; Karaca B
Transplant Proc; 2009 Mar; 41(2):751-5. PubMed ID: 19328972
[TBL] [Abstract][Full Text] [Related]
2. Impact of fluvastatin on hyperlipidemia after renal transplantation.
Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
[TBL] [Abstract][Full Text] [Related]
3. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
[TBL] [Abstract][Full Text] [Related]
4. [The effects of the short-term regular exercise-diet program on lipid profile in sedentary subjects].
Yalin S; Gök H; Toksöz R
Anadolu Kardiyol Derg; 2001 Sep; 1(3):179-8, AXV. PubMed ID: 12101821
[TBL] [Abstract][Full Text] [Related]
5. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
[TBL] [Abstract][Full Text] [Related]
6. Lowering LDL cholesterol in adults: a prospective, community-based practice initiative.
Coodley GO; Jorgensen M; Kirschenbaum J; Sparks C; Zeigler L; Albertson BD
Am J Med; 2008 Jul; 121(7):604-10. PubMed ID: 18538295
[TBL] [Abstract][Full Text] [Related]
7. Dietary treatment of hyperlipidemia in patients with systemic lupus erythematosus.
Hearth-Holmes M; Baethge BA; Broadwell L; Wolf RE
J Rheumatol; 1995 Mar; 22(3):450-4. PubMed ID: 7783060
[TBL] [Abstract][Full Text] [Related]
8. A long-term study on hyperlipidemia in stable renal transplant recipients.
Tse KC; Lam MF; Yip PS; Li FK; Lai KN; Chan TM
Clin Transplant; 2004 Jun; 18(3):274-80. PubMed ID: 15142048
[TBL] [Abstract][Full Text] [Related]
9. Primary hyperlipidemia in a pediatric population: classification and effect of dietary treatment.
Polonsky SM; Bellet PS; Sprecher DL
Pediatrics; 1993 Jan; 91(1):92-6. PubMed ID: 8416512
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin and ezetimibe in addition to nonpharmacological risk factor modification for achieving new low-density lipoprotein cholesterol targets.
Liska B; Khattab AA; Herrmann L; Abdel-Wahab M; Westphal R; Tölg R; Geist V; Richardt G
Herz; 2008 Jul; 33(5):362-7. PubMed ID: 18773156
[TBL] [Abstract][Full Text] [Related]
11. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia.
Reyna-Villasmil N; Bermúdez-Pirela V; Mengual-Moreno E; Arias N; Cano-Ponce C; Leal-Gonzalez E; Souki A; Inglett GE; Israili ZH; Hernández-Hernández R; Valasco M; Arraiz N
Am J Ther; 2007; 14(2):203-12. PubMed ID: 17414591
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K
Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of the National Cholesterol Education Program Step I diet. A randomized trial incorporating quick-service foods.
Davidson MH; Kong JC; Drennan KB; Story K; Anderson GH
Arch Intern Med; 1996 Feb; 156(3):305-12. PubMed ID: 8572841
[TBL] [Abstract][Full Text] [Related]
14. Incidence of cardiovascular risk factors and complications before and after kidney transplantation.
Fazelzadeh A; Mehdizadeh A; Ostovan MA; Raiss-Jalali GA
Transplant Proc; 2006 Mar; 38(2):506-8. PubMed ID: 16549161
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of diet in hyperlipidemia in renal transplant patients.
Zaffari D; Losekann A; Santos AF; Manfroi WC; Bittar AE; Keitel E; Souza VB; Costa M; Prates VC; Kroth L; Braun ML
Transplant Proc; 2004 May; 36(4):889-90. PubMed ID: 15194305
[TBL] [Abstract][Full Text] [Related]
16. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
17. Effects of cyclosporine-tacrolimus switching in posttransplantation hyperlipidemia on high-density lipoprotein 2/3, lipoprotein a1/b, and other lipid parameters.
Seymen P; Yildiz M; Türkmen MF; Titiz MI; Seymen HO
Transplant Proc; 2009 Dec; 41(10):4181-3. PubMed ID: 20005364
[TBL] [Abstract][Full Text] [Related]
18. Pravastatin reduces serum cholesterol and low density lipoprotein concentrations following pancreas transplantation.
al'Halawani MH; Larsen JL; Miller S; Frisbie K; Taylor RJ; Stratta RJ
Transplantation; 1994 Dec; 58(11):1204-9. PubMed ID: 7992364
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for cardiovascular disease during the first 2 years after renal transplantation.
Laurés AS; Gómez E; Baltar J; Alvarez-Grande J
Transplant Proc; 2005 Nov; 37(9):3778-81. PubMed ID: 16386536
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study.
Fernández-Miranda C; de la Calle A; Morales JM; Guijarro C; Aranda JL; Gómez-Sanz R; Gómez-Izquierdo T; Larumbe S; Moreno E; Rodicio JL; del Palacio A
Clin Transplant; 1998 Apr; 12(2):136-41. PubMed ID: 9575402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
